22 November 2017
News
21 November 2017
New mint Lesion 3.4 Software presented at RSNA 2017
With mint Lesion 3.4, reproducible assessment and structured reporting of significant image observations are easier than ever. Numerous improvements and new functionalities related to the image data handling and display streamline the image assessment. As such, for instance, a refined image series browser provides...
20 November 2017
ESOI/EORTC Workshop in Barcelona: Participants practice tumour response assessment using mint Lesion™
The autumn workshop of the European Society of Oncological Imaging (ESOI) and the European Organisation for Research and Treatment of Cancer (EORTC) is a 2.5 day interactive hands-on course that aims at training radiologists and radiology residents in the area of criteria-based tumour response assessment....
12 September 2017
Mint Medical showcases MSK-Prototype at IMR 2017 in Hamburg
Mint Medical was one of the sponsors of the first Intensive course Musculoskeletal Radiology (IMR) which took place on September 8th and 9th 2017 in Hamburg. It was organized by the board of the AG Bildgebende Verfahren des Bewegungsapparats. PD Dr. Marc Regier, its chairman,...
23 May 2017
A look ahead with mint Lesion 3.3
Mint Medical is pleased to announce the recent release of their software product version 3.3 of mint LesionTM which was completed during recent weeks. Mint Medical CEO, Dr. Matthias Baumhauer provides his insight as to what can be expected in this highly anticipated version of...
08 May 2017
New iRECIST Oncologic Response Criteria already in clinical use at the University Medical Center – Tübingen, Germany
Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen, Germany had already begun to implement this new response criteria into their clinical routine using mint LesionTM. The iRECIST guidelines are intended to provide...
23 November 2016
Mrs. Kelie Luby joins Mint Medical’s team
Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming RSNA congress in Chicago. Kelie is an experienced medical scientist and communicator with more than 18 years of clinical...
02 November 2016
Novel oncologic therapy response criteria (iRECIST and more)
Advances in oncology therapies, such as novel immune-related agents, require adapted and refined criteria and guidelines for the assessment and prediction of treatment response. At RSNA 2016, Mint Medical showcases a comprehensive set of new criteria including mRECIST mesothelioma, the Lugano (Cheson 2014 lymphoma)…
18 October 2016
Customized templates in mint Lesion 3.3
mint Lesion™ 3.3 features a novel data and knowledge modelling core that enables you to customize read procedures and reporting templates – or design them easily yourself. Among the new oncologic screening and staging guidelines, we introduce comprehensive support for ACR BI-RADS®, a refined…
29 September 2016
Data Analytics and Instant-Trial Research
Context-driven read procedures in mint Lesion™ facilitate the generation of well-structured data on a large scale. At RSNA 2016, Mint Medical presents a web-based interface to visualize and analyze all acquired data from patients and patient cohorts, as well as usage statistics allowing the monitoring…